SK biopharmaceuticals said Thursday it has signed a technology transfer agreement with a Chinese joint venture company, Ignis Therapeutics, for a non-narcotic pain treatment candidate worth 80.4 billion won ($58 million).Under the agreement, SK biopharmaceuticals will transfer the global development
Handok and Swedish Orphan Biovitrum (Sobi) said they have officially inaugurated their Korean joint venture, Handok-Sobi.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments in hematology, immunology, and specialized therapies. With 1,800 employee
GC Cell said its U.S. affiliate Artiva Biotherapeutics has begun administering the first dose to a participant in a phase 1 clinical trial. This trial investigates the combination of AlloNK (AB-101) and rituximab as a potential treatment for lupus nephritis.Lupus nephritis is a complication of syste
The Cancer Disease Review Committee (CDRC) of the Health Insurance Review and Assessment Service (HIRA) has once again deferred its decision on expanding coverage for Keytruda (pembrolizumab), as requested by MSD Korea.Nine agenda items – two new reimbursement cases and seven expanded reimbursement
After some doctors claimed that the government had not issued the Statement of Need for J-1 visas to those planning to train in U.S. hospitals, government officials said such claims were "factually incorrect."However, the medical community appears suspicious, with some saying that the government is
Celltrion said it has been awarded the national tender for the world's only infliximab subcutaneous (SC) formulation, Remsima SC, in Denmark, a key Nordic market. Under the agreement, Remsima SC will be supplied to Denmark for one year starting this month.Celltrion launched Remsima SC in Norway in F
Coreline Soft, a Korean medical AI company, said Thursday that the National Evidence-based Healthcare Collaborating Agency (NECA) has completed “notifying innovative medical technology use (clinical practice) results” for its AVIEW NeuroCAD, which was selected as an innovative medical technology.Acc
A clinical study has shown that Orafang tablets are safe for people in their 40s and 50s and for the very elderly aged 70 or more.Pharmbio Korea said Tuesday that it presented clinical results at the Seventh International Meeting on Intestinal Diseases, which was held in conjunction with the Annual
A new study is drawing attention by claiming that the types of intestinal microorganisms determine the severity of the autism spectrum.Autism spectrum disorder (ASD) is a complex disorder characterized by difficulties in social communication and interaction, repetitive behaviors, and digestive sympt
Celltrion announced its decision to further buy back and retire its own shares as part of its ongoing efforts to stabilize its stock price and enhance shareholder value.The company stated that it would purchase approximately 436,047 shares for a total acquisition cost of about 75 billion won ($54.1
President Yoon Suk Yeol's announcement to push for increasing the medical school enrollment quota and healthcare reform, even after the crushing defeat in the 22nd general election, has left the medical community stunned.The government's adamant push makes it difficult for trainee doctors to return
Generative AI has become a top investment priority for 62 percent of CEOs who manage life science companies.According to a report released by the Korea Health Industry Development Institute (KHIDI), “2024 Global Health Industry Trends In-Depth Survey," global consulting firms predicted that AI, incl
BNC Korea said it secured exclusive distribution rights in five Asian countries for Danish biotech firm Kariya's KP405 and KP404, both Alzheimer's and Parkinson's drug candidates that can cross the blood-brain barrier.The agreement, which encompasses Korea, Singapore, Thailand, Indonesia, and Malays
Almost one year has passed since the World Health Organization (WHO) declared the lifting of a Public Health Emergency of International Concern (PHEIC), but is Korea building a long-term Covid-19 management system without a hitch?On May 5, 2023, the WHO declared that Covid-19 no longer constituted a
A research team at Korea University Guro Hospital (KUGH) and Harvard Medical School has developed the "world’s first" dual fluorescence imaging technique for precision lung cancer surgery.Recent developments in lung cancer surgery aim to completely remove cancer tissues while preserving as much heal
AstraZeneca Korea's Tagrisso (osimertinib) has expanded its indication to include the first-line treatment of EGFR-mutated non-squamous NSCLC.The Ministry of Food and Drug Safety on Monday approved Tagrisso in combination with pemetrexed and platinum-based chemotherapy for the first-line treatment o
Executives of the World Medical Association (WMA) executives directly answered questions from Korean medical students who said they wanted to change the dark reality of Korean healthcare.Former and current WMA executives participated in a panel discussion at the Korean Medical Association (KMA)'s Gl
The share of workers with "five years or less" years of career in the healthcare service industry stood at 73.4 percent, higher than in other industries, a local report showed.In addition, the number of health industry workers 60 and older increased by 9.4 percent year-on-year, while the number of y
Daewoong Bio said the company has changed its entire lineup of tablets containing telmisartan, an ingredient for treating hypertension, into moisture-resistant tablets to solve the problem of hygroscopicity (the property of absorbing moisture) and renewed the bottle packaging.The ingredient telmisar
Studies have shown that high levels of distress at the time of cancer diagnosis are associated with a higher risk of recurrence and death.According to an expert, however, only 10 percent of cancer patients are assessed and diagnosed for psychiatric problems despite the emotional distress they experi
